plasminogen

1. Comparison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test
   重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较
2. Expression of urokinase-type plasminogen activator and its receptor protein in synovial tissues from osteoarthritis
   骨关节炎滑膜中尿激酶型纤溶酶原激活物及其受体蛋白的表达
3. Objective To construct an expression vector for highly efficient expression of tissue-type plasminogen activator ( t-PA) confined in the mammary gland of cow to develop a cow mammary gland bioreactor.
   目的构建组织型纤溶酶原激活剂（t-PA）乳腺定位表达载体，使其在牛乳汁中高效表达，从而建立牛乳腺生物反应器。
4. Expression of Matrix Metalloproteinase-9 and Urokinase-type Plasminogen Activator and Their Relationship with the Invasiveness of WHO Grade ⅰ Meningioma
   MMP-9和uPA的表达与WHOⅠ级脑膜瘤侵袭性的关系
5. Comparison of thrombolytic therapy with recombinant tissue plasminogen activator and urokinase for acute myocardial infarction;
   目的探讨静脉溶栓对男女急性心肌梗塞患者的疗效对比。
6. Clinical Significance of Measurement of Plasma Urokinase Type Plasminogen Activator and its Receptor in Cancer Patients
   癌症患者尿激酶型纤溶酶原激活物及其受体检测的临床意义
7. Gene expression and significance of urokinase type plasminogen activator and its receptor in oral and maxillofacial tumor tissue
   口腔颌面部恶性肿瘤尿激酶及其受体的基因表达和临床意义
8. The Initial Research about the Effect of Tissue Plasminogen Activator on Neural Repair
   组织纤溶酶原激活物对神经修复影响的初步探讨
9. Inhibitory effect of green tea polyphenols on plasminogen activator inhibitor-1 expression Something that checks or restrains
   绿茶多酚对纤溶酶原激活物抑制剂-1表达影响
10. Research Between Triglyceride and Plasminogen Activity on Abnormal in Patients with Cerebral Infarction
    脑梗死患者甘油三酯与纤溶活性异常的研究
11. Clinical significance of the expression of urokinase type plasminogen activator system in endometrial carcinoma
    子宫内膜腺癌组织中尿激酶型纤溶酶原激活系统的表达及其临床意义
12. Inhibitory effects of spironolactone on expression of plasminogen activator inhibitor-1 induced by high glucose in rat glomerular mesangial cells
    螺内酯对高糖诱导的大鼠肾小球系膜细胞PAI-1表达的抑制作用
13. Relationship between plasminogen activator system and PCOS
    纤溶酶原激活系统与多囊卵巢综合征的相关性研究
14. Expression of plasminogen activator in human bladder cancer
    纤溶酶原激活物在膀胱移行细胞癌中的表达及其意义
15. Expression, purification and identification of kringle domain deletion mutant of human plasminogen in Pichia pastoris
    人纤溶酶原kringle区缺失突变体的毕赤酵母表达、产物纯化及鉴定
16. The relation of plasma plasminogen activator inhibitor activity and coronary heart disease Relationship between plasminogen activator inhibitor 1 and neuroblastoma
    纤溶酶原激活抑制物活性与冠心病发病关系纤溶酶原激活物抑制物1与神经母细胞瘤
17. Correlation among plasma plasminogen activator inhibitor one, lipid disorder and insulin resistance in gestational diabetes mellitus
    血浆PAI-1与脂质紊乱、胰岛素抵抗及妊娠期糖尿病的相关性研究
18. Growth movement of hepatic-stellate-cell-T6 cell line and secreting law of urokinase plasminogen activator
    肝星状细胞-T6细胞系生长动态及分泌尿激酶型纤溶酶原激活物规律的研究
19. Change of plasminogen activator inhibitor type-1 in the hippocampus of diabetic rats and effect of minocycline
    糖尿病大鼠海马内PAI-1的变化及米诺环素对其的影响
20. Reciprocal activation of prourokinase and plasminogen is an important mechanism in the initiation and propagation of local fibrinolytic activity.
    纤溶酶原和尿激酶前体的相互活化作用在纤溶的开始和加速上发挥着重要的作用。
21. The high-phenol group also experienced a greater drop in the activity of another clot promoter, plasminogen activator inhibitor-1.
    高酚早餐组另一血栓促进因子&纤维蛋白溶酶原活化抑制因子-1的活性也呈现显著降低。
22. Expression of Polo-like Kinase ( PLK1) mRNA in Pterygium; Relationship between plasminogen activator inhibitor 1 and neuroblastoma
    保罗样激酶1mRNA在翼状胬肉中的表达纤溶酶原激活物抑制物1与神经母细胞瘤
23. Lysis of the hematoma with various enzymes, such as urokinase or tissue plasminogen activator ( TPA), and drainage of liquefied clot has become an alternative.
    因而，应用不同的酶如尿激酶或组织纤维蛋白溶酶原激活剂来溶解血肿和引流液化的血凝块，成为可供选择的治疗方法。
24. Effect of Arotinolol on High-sensitive C-reactive Protein and Plasminogen Activator Inhibitor-1 in Patients with Unstable Angina
    阿罗洛尔对不稳定型心绞痛患者高敏C反应蛋白和纤溶酶原激活物抑制剂-1含量的影响
25. A Case of Deficiency of Plasma Plasminogen Activator Inhibitor 1, Its Diagnosis, Treatment and Study on Molecular Abnormality
    遗传性纤溶酶原激活剂抑制物-1缺乏症的诊断、治疗及发病机理的研究
26. Relationship between the Changes of Activity of Tissue-Type Plasminogen Activator on Brains and Cerebral Edema in Asphyxia Status of Mice
    窒息鼠脑组织型纤溶酶原激活物活性变化与脑水肿的关系
27. Co-transfection of small interfering RNA to PDGF-B mRNA and tissue-type plasminogen activator gene prevents rabbit experimental restenosis
    纳米tPA基因和PDGF-B小干扰RNA预防兔实验性再狭窄
28. Effects of Thrombin-activable Fibrinolysis Inhibitor and Hirudin on Fibrinolysis; Relationship between plasminogen activator inhibitor 1 and neuroblastoma
    凝血酶激活的纤溶抑制剂与水蛭素对纤溶的影响纤溶酶原激活物抑制物1与神经母细胞瘤

noun

1. an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents